|
Volumn 29, Issue 1, 2005, Pages 38-44
|
The outsourcing advantages in formulation development
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG PRODUCTS PLANTS;
OUTSOURCING;
FORMULATION DEVELOPMENT;
PHARMACEUTICAL SPONSOR COMPANIES;
DRUG PRODUCTS;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
COMPUTER MODEL;
COMPUTER SIMULATION;
CRYSTALLIZATION;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG PACKAGING;
DRUG SOLUTION;
HEALTH SERVICE;
HIGH THROUGHPUT SCREENING;
METHODOLOGY;
REVIEW;
RISK BENEFIT ANALYSIS;
|
EID: 18844370389
PISSN: 15432521
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (1)
|